Abscint SA
2.7 FTEAbscint reported total assets of €6.85m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 2.7 full-time equivalents.
The score of Abscint shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +329 % Total assets +372 % Headcount (avg FTE) +35 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Abscint's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Abscint's financial analysis
- Solvency81.1%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abscint
Abscint's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0749.828.410
- VAT number
- BE0749828410
- Peppol
- Registered · 0208:0749828410 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Jul 2020
- Registered office
- 4000 Liège
- Size
- Micro · 2.7 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Abscint (SA) has been based in Liège since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 363,834 € and equity of €5.56m; its revenue is not published. With 2.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 81.1%, above the median of its sector (58.2%).
Companies similar to Abscint
Companies in the same business, of comparable size and area, outside its group.
- Biomedical Systems Research and experimental development on natural sciences and engineering Leuven · balance sheet €11.2m
- Aligos Belgium Research and experimental development on natural sciences and engineering Leuven · balance sheet €1.82m
- Syneos Health Belgium Research and experimental development on natural sciences and engineering Brussels · balance sheet €8.53m
- Poulpharm Research and experimental development on natural sciences and engineering Izegem · balance sheet €15.5m
- InnoSer België Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €2.12m
- BIO.BE Diagnostic imaging services and medical laboratory activities Charleroi · balance sheet €3.04m
- Dr. Timothy Boussy Diagnostic imaging services and medical laboratory activities Sint-Martens-Latem · balance sheet €1.45m
- E.H.D. BIO Diagnostic imaging services and medical laboratory activities Hannut · balance sheet €1.36m
Frequently asked questions about Abscint
What is the revenue of Abscint?
Abscint files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Abscint?
In Belgium, the VAT number is the company number prefixed with BE: BE0749828410 for Abscint, if the company is VAT-registered. Its company number (CBE) is 0749.828.410.
Where is the registered office of Abscint?
According to the CBE register, the registered office of Abscint is in 4000 Liège.
What is the equity of Abscint?
At the close of the 2025 financial year, the equity of Abscint amounts to 5,557,750 €, a solvency of 81.1% of total assets.
How many people work at Abscint?
2.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Abscint?
The register lists 10 active mandates at Abscint. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abscint
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →